Guardian Pharmacy Services, Inc. opera como proveedor de servicios farmacéuticos, ofreciendo una amplia gama de soluciones impulsadas por tecnología. Estos servicios están ...
Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal
Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a prominent player in the long-term care pharmacy sector, headquartered in Atlanta, Georgia. Founded in 2004 by Fred Burke, Kendall Forbes, and David Morris, the company has grown from a small operation to one of the nation's largest LTC pharmacy providers, serving over 195,000 residents across diverse care settings such as assisted living, behavioral health, and group homes. The company's core purpose is to deliver compassionate, community-focused pharmacy services that enhance health outcomes and reduce healthcare costs.
Guardian offers a comprehensive suite of services, including personalized clinical consultation, efficient drug distribution, and administrative support, all powered by advanced technology. Their proprietary platform, Guardian Compass, provides data analytics and insights to optimize pharmacy operations and performance. Additionally, they develop GuardianShield Programs, which are specialized safety and compliance programs tailored for long-term care facilities.
Financially, Guardian has demonstrated strong growth, with fiscal 2025 Q2 revenue reaching $344.3 million, a 15% year-over-year increase. The company's financial metrics are healthy, with a gross profit margin of 21.6%, a net profit margin of 4.5%, and a strong current ratio of 1.65. The company's market capitalization stands at approximately $2.78 billion, and it boasts a low beta of 0.10, indicating low volatility. Its IPO occurred on September 26, 2024, and it trades on the New York Stock Exchange.
The executive team is led by President and CEO Fred Burke, a co-founder with extensive industry experience. The company employs around 3,600 full-time staff, and its employee size is classified as 1001-2000. Guardian's commitment to innovation is evident in its R&D efforts, although R&D expenses are minimal. The company's future outlook is positive, with plans to expand its network and continue leveraging technology to improve care.
